FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hank Kung

Research Profile

Anatomy

Brain

Concepts & Ideas

Tissue Distribution

Living Beings

Procedures

Chemicals & Drugs

Disorders

Alzheimer's Disease

Co-author Network

Publications

TOP 3
Pinguan Zheng; Laetitia Lemoine; Brian P Lieberman; Sara Miller; Karl Ploessl; Hank F Kung
A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.
Karl Ploessl; Wenchao Qu; Limin Wang; Brian P Lieberman; Hank F Kung
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
Lin Zhu; Piu Chan; Seok-Rye Choi; Brian P Lieberman; Yajing Liu; Zhongyun Pan; Karl Ploessl; Hongwen Qiao; Jingxiao Wu; Hank F Kung
Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hank Kung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pinguan Zheng; Laetitia Lemoine; Brian P Lieberman; Sara Miller; Karl Ploessl; Hank F Kung
A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.
Bioorganic & medicinal chemistry letters 2013;23(3):869-72.
2012: Karl Ploessl; Wenchao Qu; Limin Wang; Brian P Lieberman; Hank F Kung
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(10):1616-24.
2012: Lin Zhu; Piu Chan; Seok-Rye Choi; Brian P Lieberman; Yajing Liu; Zhongyun Pan; Karl Ploessl; Hongwen Qiao; Jingxiao Wu; Hank F Kung
Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.
Nuclear medicine and biology 2012;39(7):897-904.
2012: Limin Wang; Zhihao Zha; Brian P Lieberman; Karl Plössl; Hongwen Qiao; Wenchao Qu; Hank F Kung
Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.
Nuclear medicine and biology 2012;39(7):933-43.
2012: Arthur J L Cooper; Boris Krasnikov; Hank F Kung; Jianyong Li; John Pinto; Karl Ploessl
Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 2012;163(1):108-20.
2012: Hongwen Qiao; Zhihao Zha; Lin Zhu; Brian P Lieberman; Karl Plössl; Hank F Kung
Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2012;22(13):4303-6.
2012: Seok-Rye Choi; Thomas G Beach; Barry J Bedell; David A Bennett; Franz Hefti; Michael J Krautkramer; Hank F Kung; Julie A Schneider; Daniel M Skovronsky; Simone P Zehntner; Christopher M Clark
Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Alzheimer disease and associated disorders 2012;26(1):8-16.
2012: Victor L Villemagne; Daniel M Skovronsky; Gaël Chételat; John Drago; Gareth Jones; Hank F Kung; Colin L Masters; Rachel S Mulligan; Nobuyuki Okamura; Graeme O'Keefe; Svetlana Pejoska; Michael Pontecorvo; Christopher C Rowe
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
Neuro-degenerative diseases 2012;10(1-4):161-5.
2011: Zhihao Zha; Seok-Rye Choi; Franz Hefti; Brian P Lieberman; Mark Mintun; Karl Ploessl; Wenchao Qu; Daniel M Skovronsky; Hank F Kung
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).
Journal of medicinal chemistry 2011;54(23):8085-98.
2011: Brian P Lieberman; Karl Ploessl; Wenchao Qu; Craig B Thompson; Limin Wang; David R Wise; Zhihao Zha; George Belka; Lewis A Chodosh; Hank F Kung
PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1947-55.
2011: Patrick Carberry; Alan P Carpenter; Hank F Kung
Fluoride-18 radiolabeling of peptides bearing an aminooxy functional group to a prosthetic ligand via an oxime bond.
Bioorganic & medicinal chemistry letters 2011;21(23):6992-5.
2011: Xue Zhou; Lin Zhu; Jinping Qiao; Wei Yin; Hank F Kung
Determination of the penetration of 9-fluoropropyl-(+)-dihydrotetrabenazine across the blood-brain barrier in rats by microdialysis combined with liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2011;879(28):3041-6.
2011: Wenchao Qu; Rahim Rizzi; Mathew Stetz; Craig Thompson; David Wise; Zhihao Zha; Brian P Lieberman; Anthony Mancuso; Karl Ploessl; Hank F Kung
Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism.
Academic radiology 2011;18(8):932-9.
2011: Victor L Villemagne; Daniel M Skovronsky; Henri Tochon-Danguy; Uwe Ackermann; Gaël Chételat; John Drago; Sylvia Gong; Gareth Jones; Hank F Kung; Colin L Masters; Rachel S Mulligan; Nobuyuki Okamura; Graeme J O'Keefe; Svetlana Pejoska; Christopher C Rowe
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
Archives of neurology 2011;68(7):905-12.
2011: John Lister-James; Michael J Pontecorvo; Chris Clark; Abhinay D Joshi; Mark A Mintun; Wei Zhang; Nathaniel Lim; Zhiping Zhuang; Geoff Golding; Seok-Rye Choi; Tyler E Benedum; Paul Kennedy; Franz Hefti; Alan P Carpenter; Hank F Kung; Daniel M Skovronsky
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Seminars in nuclear medicine 2011;41(4):300-4.
2011: Pinguan Zheng; Brian P Lieberman; Seok-Rye Choi; Karl Plöessl; Hank F Kung
Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
Bioorganic & medicinal chemistry letters 2011;21(11):3435-8.
2011: Jingying Liu; Lin Zhu; Karl Plössl; Brian P Lieberman; Hank F Kung
Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2011;21(10):2962-5.
2011: Zhihao Zha; Lin Zhu; Yajing Liu; Fenghua Du; Hongmei Gan; Jinping Qiao; Hank F Kung
Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.
Nuclear medicine and biology 2011;38(4):501-8.
2011: Jesse W Richardson-Jones; Thanh H Nguyen; Sheryl G Beck; Caryne P Craige; Denis J David; Alex Dranovsky; Alain M Gardier; Bruno P Guiard; René Hen; Hank F Kung; E David Leonardo
Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(16):6008-18.
2011: Patrick Carberry; Brian P Lieberman; Karl Ploessl; Seok R Choi; Danniebelle Haase; Hank F Kung
New F-18 prosthetic group via oxime coupling.
Bioconjugate chemistry 2011;22(4):642-53.
2011: Limin Wang; Brian P Lieberman; Karl Plössl; Wenchao Qu; Hank F Kung
Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.
Nuclear medicine and biology 2011;38(3):301-12.
2011: Xue Zhou; Jinping Qiao; Wei Yin; Lin Zhu; Hank F Kung
Study the effect of a pseudo-carrier on pharmacokinetics of 9-fluoropropyl-(+)-dihydrotetrabenazine in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2011;879(7-8):505-10.
2011: Wenchao Qu; Zhihao Zha; Karl Ploessl; Brian P Lieberman; Lin Zhu; David R Wise; Craig Thompson; Hank F Kung
Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors.
Journal of the American Chemical Society 2011;133(4):1122-33.
2011: Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Use of florbetapir-PET for imaging beta-amyloid pathology.
JAMA : the journal of the American Medical Association 2011;305(3):275-83.
2011: Limin Wang; Wenchao Qu; Brian P Lieberman; Karl Plössl; Hank F Kung
Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.
Nuclear medicine and biology 2011;38(1):53-62.
2010: Zhude Tu; Jinbin Xu; Lynne A Jones; Shihong Li; Dexing Zeng; Mei-Ping Kung; Hank F Kung; Robert H Mach
Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010;68(12):2268-73.
2010: Pu-Jiao Song; Céline Barc; Nicolas Arlicot; Denis Guilloteau; Serge Bernard; Pierre Sarradin; Sylvie Chalon; Lucette Garreau; Hank F Kung; Frédéric Lantier; Jackie Vergote
Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(6):576-82.
2010: Yajing Liu; Lin Zhu; Karl Plössl; Seok-Rye Choi; Hongwen Qiao; Xiaotao Sun; Song Li; Zhihao Zha; Hank F Kung
Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease.
Nuclear medicine and biology 2010;37(8):917-25.
2010: Julie L Wang; Eric C Deutsch; Shunichi Oya; Hank F Kung
FlipADAM: a potential new SPECT imaging agent for the serotonin transporter.
Nuclear medicine and biology 2010;37(5):577-86.
2010: Limin Wang; Wenchao Qu; Brian Lieberman; Karl Ploessl; Hank F Kung
Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents.
Bioorganic & medicinal chemistry letters 2010;20(12):3482-5.
2010: Dean F Wong; Paul B Rosenberg; Yun Zhou; Anil Kumar; Vanessa Raymont; Hayden T Ravert; Robert F Dannals; Ayon Nandi; James Robert Brasic; Weiguo Ye; John Hilton; Constantine G Lyketsos; Hank F Kung; Abhinay D Joshi; Daniel M Skovronsky; Michael J Pontecorvo
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(6):913-20.
2010: Julie L Wang; Shunichi Oya; Ajit K Parhi; Brian P Lieberman; Karl Ploessl; Catherine Hou; Hank F Kung
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.
Nuclear medicine and biology 2010;37(4):479-86.
2010: Hank F Kung; Seok-Rye Choi; Wenchao Qu; Wei Zhang; Daniel M Skovronsky
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Journal of medicinal chemistry 2010;53(3):933-41.
2010: Lin Zhu; Yajing Liu; Karl Plössl; Brian Lieberman; Jingying Liu; Hank F Kung
An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2.
Nuclear medicine and biology 2010;37(2):133-41.
2010: Nobuyuki Okamura; Victor L Villemagne; John Drago; Svetlana Pejoska; Rajinder K Dhamija; Rachel S Mulligan; Julia R Ellis; Uwe Ackermann; Graeme O'Keefe; Gareth Jones; Hank F Kung; Michael J Pontecorvo; Daniel Skovronsky; Christopher C Rowe
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(2):223-8.
2010: Jesse W Richardson-Jones; Caryne P Craige; Bruno P Guiard; Alisson Stephen; Kayla L Metzger; Hank F Kung; Alain M Gardier; Alex Dranovsky; Denis J David; Sheryl G Beck; René Hen; E David Leonardo
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.
Neuron 2010;65(1):40-52.
2009: Kim Serdons; Koen Van Laere; Peter Janssen; Hank F Kung; Guy Bormans; Alfons Verbruggen
Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents.
Journal of medicinal chemistry 2009;52(22):7090-102.
2009: Seok-Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(11):1887-94.
2009: Hui Qiao; Suleman Surti; Seok-Rye Choi; Karthik Raju; Hualei Zhang; Datta E Ponde; Hank F Kung; Joel Karp; Rong Zhou
Death and proliferation time course of stem cells transplanted in the myocardium.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(6):408-14.
2009: Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Hank F Kung
In vivo characterization of a series of 18F-diaryl sulfides (18F-2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)phenylthio)benzenamine) for PET imaging of the serotonin transporter.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(9):1509-17.
2009: Lin Zhu; Jingying Liu; Hank F Kung
Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2.
Bioorganic & medicinal chemistry letters 2009;19(17):5026-8.
2009: Wenchao Qu; Karl Ploessl; Hong Truong; Mei-Ping Kung; Hank F Kung
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
Bioorganic & medicinal chemistry letters 2009;19(13):3382-5.
2009: Shiaw-Pyng Wey; Chi-Chang Weng; Kun-Ju Lin; Cheng-Hsiang Yao; Tzu-Chen Yen; Hank F Kung; Daniel Skovronsky; Mei-Ping Kung
Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Nuclear medicine and biology 2009;36(4):411-7.
2009: Hui Qiao; Hualei Zhang; Yuanjie Zheng; Datta E Ponde; Dinggang Shen; Fabao Gao; Ashley B Bakken; Alexander Schmitz; Hank F Kung; Victor A Ferrari; Rong Zhou
Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection.
Radiology 2009;250(3):821-9.
2009: Ann-Marie Chacko; Eric Blankemeyer; Brian P Lieberman; Wenchao Qu; Hank F Kung
5-[18F]Fluoroalkyl pyrimidine nucleosides: probes for positron emission tomography imaging of herpes simplex virus type 1 thymidine kinase gene expression.
Nuclear medicine and biology 2009;36(1):29-38.
2009: Peter Scott; Brian G Hockley; Hank F Kung; Rajesh Manchanda; Wei Zhang; Michael R Kilbourn
Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009;67(1):88-94.
2008: Hank F Kung; Brian P Lieberman; Zhi-Ping Zhuang; Shunichi Oya; Mei-Ping Kung; Seok-Rye Choi; Karl Poessl; Eric Blankemeyer; Catherine Hou; Daniel M Skovronsky; Michael R Kilbourn
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
Nuclear medicine and biology 2008;35(8):825-37.
2008: Ann-Marie Chacko; Wenchao Qu; Hank F Kung
Synthesis and in vitro evaluation of 5-[(18)f]fluoroalkyl pyrimidine nucleosides for molecular imaging of herpes simplex virus type 1 thymidine kinase reporter gene expression.
Journal of medicinal chemistry 2008;51(18):5690-701.
2008: Wenchao Qu; Seok-Rye Choi; Catherine Hou; Zhiping Zhuang; Shunichi Oya; Wei Zhang; Mei-Ping Kung; Rajesh Manchandra; Daniel M Skovronsky; Hank F Kung
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.
Bioorganic & medicinal chemistry letters 2008;18(17):4823-7.
2008: Ann-Marie Chacko; Wenchao Qu; Hank F Kung
Synthesis of 5-fluoroalkylated pyrimidine nucleosides via Negishi cross-coupling.
The Journal of organic chemistry 2008;73(13):4874-81.
2008: Mei-Ping Kung; Catherine Hou; Brian P Lieberman; Shunichi Oya; Datta E Ponde; Eric Blankemeyer; Daniel M Skovronsky; Michael R Kilbourn; Hank F Kung
In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(7):1171-6.
2008: Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Mei-Ping Kung; Hank F Kung
2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.
Nuclear medicine and biology 2008;35(4):447-58.
2008: Karin A Stephenson; Leslie C Reid; Jon Zubieta; John Babich; Mei-Ping Kung; Hank F Kung; John F Valliant
Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides.
Bioconjugate chemistry 2008;19(5):1087-94.
2008: Pu-Jiao Song; Serge Bernard; Pierre Sarradin; Jackie Vergote; Céline Barc; Sylvie Chalon; Mei-Ping Kung; Hank F Kung; Denis Guilloteau
IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
Nuclear medicine and biology 2008;35(2):197-201.
2008: Karl Plössl; Rajesh Chandra; Wenchao Qu; Brian P Lieberman; Mei-Ping Kung; Rong Zhou; Bin Huang; Hank F Kung
A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent.
Nuclear medicine and biology 2008;35(1):83-90.
2008: Balagopal Lakshmi; Mei-Ping Kung; Brian Lieberman; Jun Zhao; Rikki Waterhouse; Hank F Kung
(R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.
Nuclear medicine and biology 2008;35(1):43-52.
2008: Izumi Maezawa; Hyun-Seok Hong; Ruiwu Liu; Chun-Yi Wu; R Holland Cheng; Mei-Ping Kung; Hank F Kung; Kit S Lam; Salvatore Oddo; Frank M LaFerla; Lee-Way Jin
Congo red and thioflavin-T analogs detect Abeta oligomers.
Journal of neurochemistry 2008;104(2):457-68.
2007: Ajit K Parhi; Julie L Wang; Shunichi Oya; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.
Journal of medicinal chemistry 2007;50(26):6673-84.
2007: Hank F Kung; Mei-Ping Kung; Shiaw-Pyng Wey; Kun-Ju Lin; Tzu-Chen Yen
Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
Nuclear medicine and biology 2007;34(7):787-9.
2007: Chenbo Zeng; Suwanna Vangveravong; Jinbin Xu; Katherine C Chang; Richard S Hotchkiss; Kenneth T Wheeler; Duanwen Shen; Zhi-Ping Zhuang; Hank F Kung; Robert H Mach
Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy.
Cancer research 2007;67(14):6708-16.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Shunichi Oya; Hank F Kung
Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.
Journal of medicinal chemistry 2007;50(14):3380-7.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Lee-Way Jin; Hank F Kung
Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection.
Bioorganic & medicinal chemistry letters 2007;17(13):3581-4.
2007: Rajesh Chandra; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Lee-Way Jin; Hank F Kung
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(10):2415-23.
2007: Wenchao Qu; Mei-Ping Kung; Catherine Hou; Tyler E Benedum; Hank F Kung
Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(9):2157-65.
2007: Mei-Ping Kung; Catherine Hou; Rajesh Goswami; Datta E Ponde; Michael R Kilbourn; Hank F Kung
Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
Nuclear medicine and biology 2007;34(3):239-46.
2007: Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Catherine Hou; Rajesh Goswami; Datta E Ponde; Mei-Ping Kung; Hank F Kung
Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
Nuclear medicine and biology 2007;34(3):233-7.
2007: Shunichi Oya; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
5-Chloro-2-(2'-((dimethylamino)methyl)-4'-iodophenylthio)benzenamine: a new serotonin transporter ligand.
Nuclear medicine and biology 2007;34(2):129-39.
2007: Karin A Stephenson; Rajesh Chandra; Zhi-Ping Zhuang; Catherine Hou; Shunichi Oya; Mei-Ping Kung; Hank F Kung
Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.
Bioconjugate chemistry 2007;18(1):238-46.
2007: Wei Zhang; Mei-Ping Kung; Shunichi Oya; Catherine Hou; Hank F Kung
18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Nuclear medicine and biology 2007;34(1):89-97.
2006: Rajesh Goswami; Datta E Ponde; Mei-Ping Kung; Catherine Hou; Michael R Kilbourn; Hank F Kung
Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
Nuclear medicine and biology 2006;33(6):685-94.
2006: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis of biphenyltrienes as probes for beta-amyloid plaques.
Journal of medicinal chemistry 2006;49(9):2841-4.
2006: Masahiro Ono; Hidekazu Kawashima; Akemi Nonaka; Tomoki Kawai; Mamoru Haratake; Hiroshi Mori; Mei-Ping Kung; Hank F Kung; Hideo Saji; Morio Nakayama
Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
Journal of medicinal chemistry 2006;49(9):2725-30.
2006: Andrew B Newberg; Nancy Wintering; Karl Plössl; John Hochold; Michael G Stabin; Marianne Watson; Daniel M Skovronsky; Christopher M Clark; Mei-Ping Kung; Hank F Kung
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):748-54.
2006: Rajesh Chandra; Mei-Ping Kung; Hank F Kung
Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
Bioorganic & medicinal chemistry letters 2006;16(5):1350-2.
2006: Catherine Hou; Zhude Tu; Robert Mach; Hank F Kung; Mei-Ping Kung
Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Nuclear medicine and biology 2006;33(2):203-9.
2005: Zijun Li; Hui Qiao; Corinna Lebherz; Seok-Rye Choi; Xiangyang Zhou; Guangping Gao; Hank F Kung; Daniel J Rader; James M Wilson; Jerry D Glickson; Rong Zhou
Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer.
Human gene therapy 2005;16(12):1429-38.
2005: Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna Maier; Hank F Kung
F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Nuclear medicine and biology 2005;32(8):799-809.
2005: Mei-Ping Kung; Hank F Kung
Mass effect of injected dose in small rodent imaging by SPECT and PET.
Nuclear medicine and biology 2005;32(7):673-8.
2005: Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna Maier; Hank F Kung
F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2005;48(19):5980-8.
2005: Seok-Rye Choi; Zhi-Ping Zhuang; Ann-Marie Chacko; Paul D Acton; Juri Tjuvajev-Gelovani; Mikhail Doubrovin; Chung (David) K. Chu; Hank F Kung
SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1).
Academic radiology 2005;12(7):798-805.
2005: Masahiro Ono; Mamoru Haratake; Morio Nakayama; Yoshikazu Kaneko; Koichi Kawabata; Hiroshi Mori; Mei-Ping Kung; Hank F Kung
Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2005;32(4):329-35.
2005: Rong Zhou; Daniel H Thomas; Hui Qiao; Harshali S Bal; Seok-Rye Choi; Abass Alavi; Victor A Ferrari; Hank F Kung; Paul D Acton
In vivo detection of stem cells grafted in infarcted rat myocardium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):816-22.
2005: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Ploessl; Hank F Kung
Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Nuclear medicine and biology 2005;32(2):171-84.
2005: Christine M Andrews; Hank F Kung; Irwin Lucki
The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens.
European journal of pharmacology 2005;508(1-3):123-30.
2004: Nicolaas P L G Verhoeff; Alan Wilson; Shinichiro Takeshita; Liat Trop; Doug Hussey; Kernjit Singh; Hank F Kung; Mei-Ping Kung; Sylvain Houle
In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(6):584-95.
2004: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Daniel M Skovronsky; Hank F Kung
Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Brain research 2004;1025(1-2):98-105.
2004: Hank F Kung; Suzanne Newman; Seok-Rye Choi; Shunichi Oya; Catherine Hou; Zhi-Ping Zhuang; Paul D Acton; Karl Plössl; Jeffrey Winkler; Mei-Ping Kung
2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.
Journal of medicinal chemistry 2004;47(21):5258-64.
2004: Hoon Choi; Seok-Rye Choi; Rong Zhou; Hank F Kung; I-Wei Chen
Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Academic radiology 2004;11(9):996-1004.
2004: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Alan J Cross; Donna Maier; Hank F Kung
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
European journal of nuclear medicine and molecular imaging 2004;31(8):1136-45.
2004: Mei-Ping Kung; Seok-Rye Choi; Catherine Hou; Zhi-Ping Zhuang; Catherine Foulon; Hank F Kung
Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
Nuclear medicine and biology 2004;31(5):533-41.
2004: Andrew B Newberg; Karl Plössl; P David Mozley; James B Stubbs; Nancy Wintering; Michelle Udeshi; Abass Alavi; Tomi Kauppinen; Hank F Kung
Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(5):834-41.
2004: Mei-Ping Kung; Zhi-Ping Zhuang; Catherine Hou; Hank F Kung
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.
Journal of molecular neuroscience : MN 2004;24(1):49-53.
2003: Grace G Shiue; Seok-Rye Choi; Ping Fang; Catherine Hou; Paul D Acton; Christopher A Cardi; Janet R Saffer; Joel Greenberg; Joel S Karp; Hank F Kung; Chyng-Yann Shiue
N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):1890-7.
2003: Alena Lira; Mingming Zhou; Nathalie Castanon; Mark Ansorge; Joshua A Gordon; Jasmine H Francis; Maria Bradley-Moore; Josko Lira; Mark D Underwood; Victoria Arango; Hank F Kung; Myron Arms Hofer; René Hen; Jay A Gingrich
Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.
Biological psychiatry 2003;54(10):960-71.
2003: Paul D Acton; Hank F Kung
Small animal imaging with high resolution single photon emission tomography.
Nuclear medicine and biology 2003;30(8):889-95.
2003: Chi-Wan Lee; Mei-Ping Kung; Catherine Hou; Hank F Kung
Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain.
Nuclear medicine and biology 2003;30(6):573-80.
2003: Masahiro Ono; Alan Wilson; Jose Nobrega; David Westaway; Paul Verhoeff; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2003;30(6):565-71.
2003: Alberto Auricchio; Paul D Acton; Markus Hildinger; Jean-Pierre Louboutin; Karl Plössl; Erin O'Connor; Hank F Kung; James M Wilson
In vivo quantitative noninvasive imaging of gene transfer by single-photon emission computerized tomography.
Human gene therapy 2003;14(3):255-61.
2003: Mei-Ping Kung; Daniel M Skovronsky; Catherine Hou; Zhi-Ping Zhuang; Tamar L Gur; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Journal of molecular neuroscience : MN 2003;20(1):15-24.
2003: Zhi-Ping Zhuang; Mei-Ping Kung; Alan Wilson; Chi-Wan Lee; Karl Plössl; Catherine Hou; David M Holtzman; Hank F Kung
Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2003;46(2):237-43.
2003: Mei-Ping Kung; Zhi-Ping Zhuang; Catherine Hou; Lee-Way Jin; Hank F Kung
Characterization of radioiodinated ligand binding to amyloid beta plaques.
Journal of molecular neuroscience : MN 2003;20(3):249-54.
2003: Hank F Kung; Mei-Ping Kung; Seok-Rye Choi
Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
Seminars in nuclear medicine 2003;33(1):2-13.
2002: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Bin Zhang; Daniel M Skovronsky; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Brain research 2002;956(2):202-10.
2002: Paul D Acton; Catherine Hou; Mei-Ping Kung; Karl Plössl; Cindy L Keeney; Hank F Kung
Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
European journal of nuclear medicine and molecular imaging 2002;29(11):1507-15.
2002: Yiyun Huang; Dah-Ren Hwang; Rajesh Narendran; Yasuhiko Sudo; Rano Chatterjee; Sung-A Bae; Osama Mawlawi; Lawrence S Kegeles; Alan A Wilson; Hank F Kung; Marc Laruelle
Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2002;22(11):1377-98.
2002: Shunichi Oya; Seok-Rye Choi; Heinz Coenen; Hank F Kung
New PET imaging agent for the serotonin transporter: [(18)F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine).
Journal of medicinal chemistry 2002;45(21):4716-23.
2002: Klaus-Henning Krause; Stefan Dresel; Johanna Krause; Hank F Kung; Klaus Tatsch; Hanns Lochmüller
Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
Journal of neurology 2002;249(8):1116-8.
2002: Masahiro Ono; Mei-Ping Kung; Catherine Hou; Hank F Kung
Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2002;29(6):633-42.
2002: Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Daniel M Skovronsky; Bin Zhang; Tamar L Gur; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
Journal of molecular neuroscience : MN 2002;19(1-2):7-10.
2002: Klaus-Henning Krause; Stefan Dresel; Johanna Krause; Hank F Kung; Klaus Tatsch; Manfred Ackenheil
Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2002;5(2):111-3.
2002: Paul D Acton; Seok-Rye Choi; Karl Plössl; Hank F Kung
Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography.
European journal of nuclear medicine and molecular imaging 2002;29(5):691-8.
2002: Paul D Acton; Mei-Ping Kung; Catherine Hou; Karl Plössl; Cindy Keeney; Hank F Kung
Ultra-high resolution single photon emission tomography imaging of the mouse striatum.
European journal of nuclear medicine and molecular imaging 2002;29(3):446.
2001: Hank F Kung; Chi-Wan Lee; Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Plössl
Novel stilbenes as probes for amyloid plaques.
Journal of the American Chemical Society 2001;123(50):12740-1.
2001: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Karl Plössl; Daniel M Skovronsky; Tamar L Gur; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain.
Nuclear medicine and biology 2001;28(8):887-94.
2001: Paul D Acton; Seok-Rye Choi; Catherine Hou; Karl Plössl; Hank F Kung
Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(10):1556-62.
2001: Seok-Rye Choi; B Yang; Karl Plössl; S Chumpradit; Shiaw-Pyng Wey; Paul D Acton; K Wheeler; R H Mach; Hank F Kung
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
Nuclear medicine and biology 2001;28(6):657-66.
2001: Chi-Wan Lee; Zhi-Ping Zhuang; Mei-Ping Kung; Karl Plössl; Daniel M Skovronsky; Tamar L Gur; Catherine Hou; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
Journal of medicinal chemistry 2001;44(14):2270-5.
2001: Hank F Kung
Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent.
Nuclear medicine and biology 2001;28(5):505-8.
2001: Zhi-Ping Zhuang; Mei-Ping Kung; Catherine Hou; Daniel M Skovronsky; Tamar L Gur; Karl Plössl; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
Journal of medicinal chemistry 2001;44(12):1905-14.
2000: Seok-Rye Choi; Catherine Hou; Shunichi Oya; M Mu; Mei-Ping Kung; M Siciliano; Paul D Acton; Hank F Kung
Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
Synapse (New York, N.Y.) 2000;38(4):403-12.
2000: Gregg D Stanwood; R P Artymyshyn; Mei-Ping Kung; Hank F Kung; Irwin Lucki; P McGonigle
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1223-31.
2000: Paul D Acton; Philipp T Meyer; P David Mozley; Karl Plössl; Hank F Kung
Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography.
European journal of nuclear medicine 2000;27(11):1714-8.
2000: Stefan Dresel; Johanna Krause; Klaus-Henning Krause; C LaFougere; Kirsten Brinkbäumer; Hank F Kung; Klaus Hahn; Klaus Tatsch
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
European journal of nuclear medicine 2000;27(10):1518-24.
2000: Daniel M Skovronsky; Bin Zhang; Mei-Ping Kung; Hank F Kung; John Q Trojanowski; Virginia M-Y Lee
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7609-14.
2000: Klaus-Henning Krause; Stefan Dresel; Johanna Krause; Hank F Kung; Klaus Tatsch
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
Neuroscience letters 2000;285(2):107-10.
2000: Shunichi Oya; Seok-Rye Choi; Catherine Hou; M Mu; Mei-Ping Kung; Paul D Acton; M Siciliano; Hank F Kung
2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
Nuclear medicine and biology 2000;27(3):249-54.
2000: P David Mozley; Jay S Schneider; Paul D Acton; Karl Plössl; Matthew B Stern; Andrew Siderowf; N A Leopold; P Y Li; Abass Alavi; Hank F Kung
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):584-9.
2000: DA Knobelman; Hank F Kung; Irwin Lucki
Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1111-7.
2000: Z Zhuang; S Choi; Catherine Hou; M Mu; M Kung; Paul D Acton; Hank F Kung
A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
Nuclear medicine and biology 2000;27(2):169-75.
1999: P David Mozley; Paul D Acton; ED Barraclough; Karl Plössl; Ruben C Gur; Abass Alavi; A Mathur; Janet R Saffer; Hank F Kung
Effects of age on dopamine transporters in healthy humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(11):1812-7.
1999: Paul D Acton; P David Mozley; Hank F Kung
Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease.
European journal of nuclear medicine 1999;26(11):1413-23.
1999: Y Xu; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs.
Nuclear medicine and biology 1999;26(7):833-9.
1999: M Mu; Mei-Ping Kung; Karl Plössl; Paul D Acton; P David Mozley; Hank F Kung
A simplified method to determine [99mTc]TRODAT-1 in human plasma.
Nuclear medicine and biology 1999;26(7):821-5.
1999: Paul D Acton; M Mu; Karl Plössl; Catherine Hou; M Siciliano; Zhi-Ping Zhuang; Shunichi Oya; Seok-Rye Choi; Hank F Kung
Single-photon emission tomography imaging of serotonin transporters in the nonhuman primate brain with [(123)I]ODAM.
European journal of nuclear medicine 1999;26(10):1359-62.
1999: Paul D Acton; Mei-Ping Kung; M Mu; Karl Plössl; Catherine Hou; M Siciliano; Shunichi Oya; Hank F Kung
Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
European journal of nuclear medicine 1999;26(8):854-61.
1999: Mei-Ping Kung; Catherine Hou; Shunichi Oya; M Mu; Paul D Acton; Hank F Kung
Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
European journal of nuclear medicine 1999;26(8):844-53.
1999: Paul D Acton; L S Pilowsky; Hank F Kung; P J Ell
Automatic segmentation of dynamic neuroreceptor single-photon emission tomography images using fuzzy clustering.
European journal of nuclear medicine 1999;26(6):581-90.
1999: Seok-Rye Choi; Mei-Ping Kung; Karl Plössl; SK Meegalla; Hank F Kung
An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1.
Nuclear medicine and biology 1999;26(4):461-6.
1999: Paul D Acton; SA Kushner; Mei-Ping Kung; P David Mozley; Karl Plössl; Hank F Kung
Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
European journal of nuclear medicine 1999;26(5):518-26.
1999: SH Dresel; Mei-Ping Kung; X F Huang; Karl Plössl; Catherine Hou; SK Meegalla; G Patselas; M Mu; Janet R Saffer; Hank F Kung
Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):660-6.
1999: SH Dresel; Mei-Ping Kung; X Huang; Karl Plössl; Catherine Hou; Chyng-Yann Shiue; Jonathan Karp; Hank F Kung
In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
European journal of nuclear medicine 1999;26(4):342-7.
1999: Zhi-Ping Zhuang; Mei-Ping Kung; M Mu; Catherine Hou; Hank F Kung
99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Bioconjugate chemistry 1999;10(2):159-68.
1999: Shunichi Oya; Mei-Ping Kung; Paul D Acton; M Mu; Catherine Hou; Hank F Kung
A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.
Journal of medicinal chemistry 1999;42(3):333-5.
1999: Zhi-Ping Zhuang; Karl Plössl; Mei-Ping Kung; M Mu; Hank F Kung
Neutral and stereospecific Tc-99m complexes: [99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT).
Nuclear medicine and biology 1999;26(2):217-24.
1999: SA Kushner; WT McElgin; Mei-Ping Kung; P David Mozley; Karl Plössl; SK Meegalla; M Mu; SH Dresel; JM Vessotskie; N Lexow; Hank F Kung
Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):150-8.
1998: P David Mozley; James B Stubbs; Karl Plössl; SH Dresel; ED Barraclough; Abass Alavi; Luis Araujo; Hank F Kung
Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2069-76.
1998: Sylvie Ramboz; Ronald Oosting; D A Amara; Hank F Kung; Pierre Blier; Monica Mendelsohn; J John Mann; Dani Brunner; René Hen
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14476-81.
1998: SK Meegalla; Karl Plössl; Mei-Ping Kung; DA Stevenson; M Mu; SA Kushner; L M Liable-Sands; A L Rheingold; Hank F Kung
Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Journal of medicinal chemistry 1998;41(4):428-36.
1998: Shunichi Oya; Karl Plössl; Mei-Ping Kung; DA Stevenson; Hank F Kung
Small and neutral Tc(v)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents.
Nuclear medicine and biology 1998;25(2):135-40.
1998: Zhi-Ping Zhuang; Mei-Ping Kung; M Mu; Hank F Kung
Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Journal of medicinal chemistry 1998;41(2):157-66.
1998: SH Dresel; Mei-Ping Kung; Karl Plössl; SK Meegalla; Hank F Kung
Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
European journal of nuclear medicine 1998;25(1):31-9.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Brain research 1997;778(1):89-98.
1997: JM Vessotskie; Mei-Ping Kung; S Chumpradit; Hank F Kung
Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Neuropharmacology 1997;36(7):999-1007.
1997: A R Allen; A Singh; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung; Irwin Lucki
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1997;57(1-2):301-7.
1997: Klaus Tatsch; Johannes Schwarz; PD Mozley; Rainer Linke; Oliver Pogarell; Wolfgang H Oertel; R S Fieber; Klaus Hahn; Hank F Kung
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
European journal of nuclear medicine 1997;24(4):415-21.
1997: Mei-Ping Kung; DA Stevenson; Karl Plössl; SK Meegalla; A Beckwith; W D Essman; M Mu; I Lucki; Hank F Kung
[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
European journal of nuclear medicine 1997;24(4):372-80.
1997: Chyng-Yann Shiue; Grace G Shiue; P David Mozley; Mei-Ping Kung; Zhi-Ping Zhuang; H J Kim; Hank F Kung
P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
Synapse (New York, N.Y.) 1997;25(2):147-54.
1997: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; SA Kushner; WT McElgin; P David Mozley; Hank F Kung
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Journal of medicinal chemistry 1997;40(1):9-17.
1997: Mei-Ping Kung; DA Stevenson; Zhi-Ping Zhuang; JM Vessotskie; S Chumpradit; X M Sun; Hank F Kung
Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Life sciences 1997;60(2):91-100.
1996: Robert H Mach; Michael A Nader; Richard L Ehrenkaufer; SW Line; CR Smith; R R Luedtke; Mei-Ping Kung; Hank F Kung; David Lyons; Thomas E Morton
Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
Synapse (New York, N.Y.) 1996;24(4):322-33.
1996: P David Mozley; H J Kim; Ruben C Gur; Klaus Tatsch; L R Muenz; W T McElgin; Mei-Ping Kung; M Mu; A M Myers; Hank F Kung
Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1965-70.
1996: Hank F Kung; D Frederick; H J Kim; W McElgin; Mei-Ping Kung; M Mu; P David Mozley; JM Vessotskie; DA Stevenson; SA Kushner; Zhi-Ping Zhuang
In vivo SPECT imaging of 5-HT1A receptors with [123I]p-MPPI in nonhuman primates.
Synapse (New York, N.Y.) 1996;24(3):273-81.
1996: Hank F Kung; H J Kim; Mei-Ping Kung; SK Meegalla; Karl Plössl; H K Lee
Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
European journal of nuclear medicine 1996;23(11):1527-30.
1996: Hank F Kung; DA Stevenson; Zhi-Ping Zhuang; Mei-Ping Kung; D Frederick; S D Hurt
New 5-HT1A receptor antagonist: [3H]p-MPPF.
Synapse (New York, N.Y.) 1996;23(4):344-6.
1996: Shunichi Oya; Mei-Ping Kung; D Frederick; Hank F Kung
Novel TcVO(III) N2S2 complexes: interconversion by redox reaction.
Nuclear medicine and biology 1996;23(5):589-93.
1996: SK Meegalla; Karl Plössl; Mei-Ping Kung; S Chumpradit; DA Stevenson; D Frederick; Hank F Kung
Tc-99m-labeled tropanes as dopamine transporter imaging agents.
Bioconjugate chemistry 1996;7(4):421-9.
1996: Mei-Ping Kung; M Mu; Zhi-Ping Zhuang; Hank F Kung
NCS-MPP (4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-isothiocyanobenz amido]-ethyl-piperazine): a high affinity and irreversible 5-HT1A receptor ligand.
Life sciences 1996;58(3):177-86.
1996: P David Mozley; J B Stubbs; H J Kim; W McElgin; Mei-Ping Kung; SK Meegalla; Hank F Kung
Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):151-9.
1995: Robert T Malison; JM Vessotskie; Mei-Ping Kung; W McElgin; G Romaniello; H J Kim; Mark M Goodman; Hank F Kung
Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2290-7.
1995: Shunichi Oya; Mei-Ping Kung; D Frederick; Hank F Kung
New bisaminoethanethiol (BAT) ligands which form two interconvertible Tc-99m complexes.
Nuclear medicine and biology 1995;22(6):749-57.
1995: Mei-Ping Kung; W D Essman; D Frederick; SK Meegalla; Mark M Goodman; M Mu; Irwin Lucki; Hank F Kung
IPT: a novel iodinated ligand for the CNS dopamine transporter.
Synapse (New York, N.Y.) 1995;20(4):316-24.
1995: P David Mozley; J B Stubbs; H J Kim; W McElgin; S Chumpradit; Mei-Ping Kung; G Romaniello; Hank F Kung
Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1322-31.
1995: JM Vessotskie; Mei-Ping Kung; S Chumpradit; G Romaniello; W McElgin; D Frederick; Robert T Malison; Hank F Kung
In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1282-8.
1995: Marc Laruelle; Anissa Abi-Dargham; Christopher H van Dyck; William H Rosenblatt; Yolanda Zea-Ponce; Sami S Zoghbi; Ronald M Baldwin; D S Charney; PB Hoffer; Hank F Kung
SPECT imaging of striatal dopamine release after amphetamine challenge.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1182-90.
1995: K D Burris; M A Pacheco; T M Filtz; Mei-Ping Kung; Hank F Kung; P B Molinoff
Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(4):335-45.
1995: D J Canney; Mei-Ping Kung; Hank F Kung
Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
Nuclear medicine and biology 1995;22(4):527-35.
1995: Mei-Ping Kung; D Frederick; M Mu; Zhi-Ping Zhuang; Hank F Kung
4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
The Journal of pharmacology and experimental therapeutics 1995;272(1):429-37.
1995: Zhi-Ping Zhuang; Mei-Ping Kung; W Clarke; S Maayani; M Mu; Hank F Kung
Synthesis of (+)-(R)- and (-)-(S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)] aminotetralin: new 5-HT1A receptor ligands.
Chirality 1995;7(6):452-8.
1994: Zhi-Ping Zhuang; Mei-Ping Kung; S Chumpradit; M Mu; Hank F Kung
Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands.
Journal of medicinal chemistry 1994;37(26):4572-5.
1994: Mei-Ping Kung; Zhi-Ping Zhuang; D Frederick; Hank F Kung
In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
Synapse (New York, N.Y.) 1994;18(4):359-66.
1994: Mei-Ping Kung; S Chumpradit; D Frederick; S Garner; K D Burris; P B Molinoff; Hank F Kung
Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(6):611-7.
1994: S Chumpradit; Mei-Ping Kung; JM Vessotskie; C Foulon; M Mu; Hank F Kung
Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Journal of medicinal chemistry 1994;37(24):4245-50.
1994: Mei-Ping Kung; D J Canney; D Frederick; Z Zhuang; J J Billings; Hank F Kung
Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites.
Synapse (New York, N.Y.) 1994;18(3):225-32.
1994: L C Francesconi; Y Y Yang; Mei-Ping Kung; X X Zhang; J J Billings; Y Z Guo; Hank F Kung
Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand.
Journal of medicinal chemistry 1994;37(20):3282-8.
1994: Marc Laruelle; Mohammed S Al-Tikriti; Yolanda Zea-Ponce; Sami S Zoghbi; Ronald M Baldwin; D S Charney; PB Hoffer; Hank F Kung; Robert B Innis
In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography.
European journal of pharmacology 1994;263(1-2):39-51.
1994: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.
Journal of medicinal chemistry 1994;37(10):1406-7.
1994: Marc Laruelle; Christopher H van Dyck; Anissa Abi-Dargham; Yolanda Zea-Ponce; Sami S Zoghbi; D S Charney; Ronald M Baldwin; PB Hoffer; Hank F Kung; Robert B Innis
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(5):743-54.
1994: L Shao; J Billings; N Pfeiffer; Hank F Kung
Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys.
Medical physics 1994;21(5):675-81.
1994: K D Burris; T M Filtz; S Chumpradit; Mei-Ping Kung; C Foulon; Julie Hensler; Hank F Kung; P B Molinoff
Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
The Journal of pharmacology and experimental therapeutics 1994;268(2):935-42.
1994: S E Garner; Mei-Ping Kung; C Foulon; S Chumpradit; Hank F Kung
[125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Life sciences 1994;54(9):593-603.
1994: Hank F Kung; Mei-Ping Kung; W Clarke; S Maayani; Zhi-Ping Zhuang
A potential 5-HT1A receptor antagonist: p-MPPI.
Life sciences 1994;55(19):1459-62.
1993: S Chumpradit; Mei-Ping Kung; Hank F Kung
Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(26):4308-12.
1993: J J Billings; Y Z Guo; Mei-Ping Kung; Hank F Kung
Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
European journal of nuclear medicine 1993;20(12):1146-53.
1993: P David Mozley; J B Stubbs; Hank F Kung; M H Selikson; Michael G Stabin; Abass Alavi
Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):1910-7.
1993: Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
Journal of medicinal chemistry 1993;36(21):3161-5.
1993: C Foulon; Mei-Ping Kung; Hank F Kung
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(10):1499-500.
1993: Y Z Guo; Mei-Ping Kung; H Cheng; N Pfeiffer; D Mozley; Hank F Kung
A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note.
European journal of nuclear medicine 1993;20(5):373-8.
1993: Mei-Ping Kung; Hank F Kung; S Chumpradit; C Foulon
In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
European journal of pharmacology 1993;235(1):165-6.
1993: D J Canney; J Billings; L C Francesconi; Y Z Guo; B S Haggerty; A L Rheingold; Hank F Kung
Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
Journal of medicinal chemistry 1993;36(8):1032-40.
1993: P David Mozley; X Zhu; Hank F Kung; M H Selikson; J Hickey; S Galloway; N Pfieffer; Abass Alavi
The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(2):208-13.
1993: S Chumpradit; Mei-Ping Kung; J Billings; Robert H Mach; Hank F Kung
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Journal of medicinal chemistry 1993;36(2):221-8.
1992: S Chumpradit; Mei-Ping Kung; C Panyachotipun; V Prapansiri; C Foulon; B P Brooks; S A Szabo; Shanaz Tejani-Butt; Alan Frazer; Hank F Kung
Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites.
Journal of medicinal chemistry 1992;35(23):4492-7.
1992: Y Ohmomo; L Francesconi; Mei-Ping Kung; Hank F Kung
New conformationally restricted 99mTc N2S2 complexes as myocardial perfusion imaging agents.
Journal of medicinal chemistry 1992;35(1):157-62.
1992: J J Billings; Mei-Ping Kung; S Chumpradit; D Mozley; Abass Alavi; Hank F Kung
Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Journal of neurochemistry 1992;58(1):227-36.
1991: S Chumpradit; Mei-Ping Kung; J J Billings; Hank F Kung
Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
Journal of medicinal chemistry 1991;34(3):877-83.
1991: Mei-Ping Kung; B L Liu; Y Y Yang; J J Billings; Hank F Kung
A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(2):339-42.
1991: Robert H Mach; Hank F Kung; P Jungwiwattanaporn; Y Z Guo
Synthesis and biodistribution of a new class of 99mTc-labeled fatty acid analogs for myocardial imaging.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):215-26.
1991: Hank F Kung
Overview of radiopharmaceuticals for diagnosis of central nervous disorders.
Critical reviews in clinical laboratory sciences 1991;28(4):269-86.
1991: C S John; Mei-Ping Kung; J Billings; Hank F Kung
Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(5):551-6.
1990: T M Filtz; S Chumpradit; Hank F Kung; P B Molinoff
Synthesis and applications of an aldehyde-containing analogue of SCH-23390.
Bioconjugate chemistry 1990;1(6):394-9.
1990: Hank F Kung; Y Ohmomo; M P Kung
Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography.
Seminars in nuclear medicine 1990;20(4):290-302.
1990: Hank F Kung; B L Liu; D Mankoff; Mei-Ping Kung; J J Billings; L Francesconi; Abass Alavi
A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(10):1635-40.
1990: R R Luedtke; M Bush; Robert H Mach; R E Ehrenkaufer; Hank F Kung; P B Molinoff
Antibodies with high affinity for spiroperidol--II. Cross reactivity with iodobenzamide and domperidone.
Molecular immunology 1990;27(7):667-77.
1990: Mei-Ping Kung; Hank F Kung; J Billings; Y Yang; R A Murphy; Abass Alavi
The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):648-54.
1990: Hank F Kung; Abass Alavi; W Chang; Mei-Ping Kung; J W Keyes; M G Velchik; J Billings; S Pan; R Noto
In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):573-9.
1990: Hank F Kung
New technetium 99m-labeled brain perfusion imaging agents.
Seminars in nuclear medicine 1990;20(2):150-8.
1990: Hank F Kung; B L Liu; Y Wei; S Pan
Quantitative study of the structure-stability relationship of TcvO(III) complexes.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1990;41(8):773-81.
1990: Hank F Kung
Radiopharmaceuticals for CNS receptor imaging with SPECT.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(1):85-92.
1990: R A Murphy; Hank F Kung; Mei-Ping Kung; J Billings
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Journal of medicinal chemistry 1990;33(1):171-8.
1989: B S Schonwetter; R R Luedtke; Mei-Ping Kung; J Billings; Hank F Kung; P B Molinoff
Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
The Journal of pharmacology and experimental therapeutics 1989;250(1):110-6.
1989: S Chumpradit; Hank F Kung; J Billings; Mei-Ping Kung; S Pan
(+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.
Journal of medicinal chemistry 1989;32(7):1431-5.
1989: S Chumpradit; Hank F Kung; J Billings; Y Z Guo; Y Wu; J Shih
Preparation and biodistribution of 1-[2-(3-[125I]iodo-4-aminophenyl)ethyl]-4-[3-(trifluoromethyl) phenyl]piperazine and 1-[2-(3-[125I]iodo-4-azidophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl] piperazine.
Journal of medicinal chemistry 1989;32(3):543-7.
1989: Hank F Kung; Y Z Guo; C C Yu; J Billings; V Subramanyam; J C Calabrese
New brain perfusion imaging agents based on 99mTc-bis(aminoethanethiol) complexes: stereoisomers and biodistribution.
Journal of medicinal chemistry 1989;32(2):433-7.
1989: Hank F Kung; S Pan; Mei-Ping Kung; J Billings; R Kasliwal; J Reilley; Abass Alavi
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(1):88-92.
1989: J Billings; Mei-Ping Kung; S Chumpradit; S Pan; Hank F Kung
[125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.
Life sciences 1989;45(8):711-8.
1989: Robert H Mach; Hank F Kung; Y Z Guo; C C Yu; V Subramanyam; J C Calabrese
Synthesis, characterization and biodistribution of neutral and lipid-soluble 99mTc-PAT-HM and 99mTc-TMR for brain imaging.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(8):829-37.
1988: S M N Efange; Hank F Kung; J J Billings; M Blau
Synthesis and biodistribution of 99mTc-labeled piperidinyl bis(aminoethanethiol) complexes: potential brain perfusion imaging agents for single photon emission computed tomography.
Journal of medicinal chemistry 1988;31(5):1043-7.
1988: Hank F Kung; R Kasliwal; S G Pan; Mei-Ping Kung; Robert H Mach; Y Z Guo
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Journal of medicinal chemistry 1988;31(5):1039-43.
1988: Hank F Kung; J Billings; E Farrell; M Blau
Effect of anesthetics on the uptake of brain imaging agents in rats.
American journal of physiologic imaging 1988;3(1):36.
1988: Hank F Kung; J J Billings; Y Z Guo; Robert H Mach
Comparison of in vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(2):203-8.
1988: Hank F Kung; Y Z Guo; J Billings; X Xu; Robert H Mach; M Blau; R E Ackerhalt
Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(2):195-201.
1988: Hank F Kung; J J Billings; Y Z Guo; M Blau; R Ackerhalt
Preparation and biodistribution of [125I]IBZP: a potential CNS D-1 dopamine receptor imaging agent.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(2):187-93.
1987: S M N Efange; Hank F Kung; J Billings; Y Z Guo; M Blau
Technetium-99m bis (aminoethanethiol) complexes with amine sidechains--potential brain perfusion imaging agents for SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(6):1012-9.
1987: B Lui; J Chang; J S Sun; J Billings; A Steves; R Ackerhalt; M Molnar; Hank F Kung
Radioactive iodine exchange reaction of HIPDM: kinetics and mechanism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(3):360-5.
1987: B L Liu; Hank F Kung; J Billings; M Blau
Comparison of [82Br]4-bromoantipyrine and [125I]4-iodoantipyrine: the kinetics of exchange reaction and biodistribution in rats.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(1):69-74.
1985: Hank F Kung; C C Yu; J Billings; M Molnar; M Blau
Synthesis of new bis(aminoethanethiol) (BAT) derivatives: possible ligands for 99mTc brain imaging agents.
Journal of medicinal chemistry 1985;28(9):1280-4.
1985: Hank F Kung; J Billings; E Farrell; M Blau
The effect of anaesthetics on the uptake of brain-imaging agents in rats.
Nuclear medicine communications 1985;6(2):75-81.
1984: Hank F Kung; M Molnar; J Billings; R Wicks; M Blau
Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(3):326-32.